Home       BioDefense Research & Development Monthly - Y2007 #01
DATE SOURCE OTHER PARTY INVOLVED NBC THREAT / TYPE HEADLINES - CLICK TO VIEW FULL RELEASE
De (Detection), Di (Diagnostic), Dr (Drug), Ot (Other), Va (Vaccine)
02/13/07 Crucell (NL) Vaccine Research Center (US) Ebola (Va) Crucell announces fourth quarter and annual results 2006
02/13/07 SIGA Technologies (US)   Smallpox (Dr) SIGA Begins Second Human Safety Trial of Its Lead Smallpox Drug
02/13/07 Universal Detection Technology (US)   Anthrax (De) Universal Detection Technology's CEO Purchases 100,000,000 Shares of Common Stock of Universal Detection Technology
02/12/07 Accium BioSciences (US) Affinium Pharmaceuticals (US) Tularemia (Dr) Accium BioSciences to Provide Microdosing Services to Affinium Pharmaceuticals in Support of a Biodefense Research Contract
02/12/07 Emergent BioSolutions (US)   Anthrax (Va) FDA Grants Fast Track Designation to Emergent BioSolutions’ BioThrax® for Post-Exposure Prophylaxis against Anthrax Infection
02/12/07 Scripps Research Institute (US)   Botulism (Dr) Compounds Show Significant Promise Against Potential Bioweapon Toxins
02/09/07 DOR BioPharma (US)   Various (Va) DOR BioPharma Raises $5.5 Million in Private Equity Financing
02/08/07 Colorado State University (US)   Various (Di, Va) Colorado State University Research-to-Market Entity Advances Global Health Solutions
02/07/07 Affymetrix (US) Tessarae (US) Various (De) Affymetrix Reports Fourth Quarter and Fiscal Year 2006 Results
02/07/07 Alnylam Pharmaceuticals (US)   Various (Dr) Alnylam Pharmaceuticals Reports Fourth Quarter and 2006 Financial Results
02/07/07 Universal Detection Technology (US) Security Solutions International (US) Anthrax (De) Universal Detection Technology Receives Additional Purchase Order for Five More of Company's Bio-Warfare Test Kits From Security Solutions International
02/05/07 Response Biomedical (CA)   Various (De) Response Biomedical Announces Succession Plan
02/02/07 AlphaVax (US)   Various (Va) AlphaVax Announces the Closing of Its Series E Investment Offering
02/02/07 Bavarian Nordic (SK) GlaxoSmithKline (UK) Smallpox (Va) Bavarian Nordic and GSK to Terminate Collaboration
01/31/07 EpiVax (US)   Tularemia (Va) Rhode Island Biotechnology Company Develops Tularemia Vaccine
01/31/07 SIGA Technologies (US)   Various (Dr, Va) SIGA Appoints Dr. Eric A. Rose Chairman of the Board, Will Become CEO on March 1, 2007
01/29/07 Medical Services International (CA)   Dengue fever (Di) Medical Services International Moves Into Additional Countries in Africa
01/26/07 Crucell (NL)   West Nile virus ((Va) Crucell's PER.C6®-based West Nile Vaccine Demonstrates Excellent Safety and Tolerability
01/26/07 Cumberland Emerging Technologies (US) Microbial Novoteqs (US) Various (Dr) Microbial Novoteqs Expands Presence, Creates Jobs at CET Life Sciences Center
01/26/07 CytoGenix (US)   Various (Va) CytoGenix' 2006 - Year in Review
01/25/07 Novartis (SG)   Dengue fever (Dr) Novartis Institute for Tropical Diseases inaugurates new Indonesian research initiative to study dengue fever, tuberculosis and malaria
01/23/07 Affymetrix (US) Tessarae (US) Various (De) Affymetrix and Tessarae Collaborate to Help Researchers Better Respond to Biodefense and Pandemic Infectious Disease Threats
01/22/07 Aethlon Medical (US)   Ebola (Ot) Aethlon Medical Announces Government Research Collaborations
01/22/07 Bavarian Nordic (SK) Acambis (UK) Smallpox (Va) U.S. International Trade Commission requests additional briefing relating to remedy
01/22/07 PharmAthene (US) Healthcare Acquisition (US) Various (Dr) PharmAthene and Healthcare Acquisition Corp. Announce Definitive Merger Agreement
01/19/07 Acambis (UK)   Various (Va) Acambis appoints Head of Research and Development
01/19/07 DOR BioPharma (US) Cell Therapeutics (US) Various (Va) DOR BioPharma Receives Unsolicited Acquisition Proposal From Cell Therapeutics
01/18/07 Carrington Laboratories (US) DelSite Biotechnologies (US) Various Carrington Responds to Recent Press on Bird Flu Pandemic and Issues Update on DelSite Platform Technology
01/18/07 CSC DVC (US) Baxter (US) Chemical nerve agents (Dr) CSC's DVC and Baxter Begin Phase 1 Clinical Trial for Chemical Defense Product
01/18/07 ImmuneRegen BioSciences (US) Battelle (US) Various (Dr) ImmuneRegen BioSciences, Inc. Retains Battelle for Radiation and Infectious Disease Testing
01/18/07 Scripps Research Institute (US)   Botulism (Dr, Va) Study Reveals Molecular Basis of Botulism Toxin's Deadly Activity
01/17/07 Acambis (UK)   Smallpox (Va) Acambis receives Complete Response Letter from FDA on ACAM2000 Biologics Licence Application